[Clinical study of imipenem/cilastatin sodium in serious infections in critical care medical center].

@article{Sakata1993ClinicalSO,
  title={[Clinical study of imipenem/cilastatin sodium in serious infections in critical care medical center].},
  author={Ikuko Sakata and Junichi Maruyama and Hakuo Takahashi and Hiroaki Kitagishi and Miyuki Nakaji and Hitoshi Yoshinobu and Yuria Mantani and Kunitaka Maruyama and Hiroshi Iwaki and Toshiharu Matsushima},
  journal={The Japanese journal of antibiotics},
  year={1993},
  volume={46 5},
  pages={
          397-403
        }
}
Patients with severe trauma and illness were treated at our critical care medical center. Many of these patients have diabetes, anemia and other underlying conditions which sometimes lead to serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or Pseudomonas aeruginosa. A clinical study imipenem/cilastatin sodium (IPM/CS) was performed at our Medical Center. IPM/CS was administered to 30 patients with serious infections. Clinical results were excellent in 11, good in… CONTINUE READING

Similar Papers

Loading similar papers…